According to a study by Grosu et al.,28 there was a strong correlation between the expression of PD‐L1 in histology samples and matching pleural fluid from NSCLC patients, suggesting that if the primary tumor was responsive to anti‐PD‐1 therapy, MPE might also potentially be impacted by this therapy. The gene discussed is CD274; the disease is non-small cell lung carcinoma.